Not all medications can be changed, but many patients experience improvement when adjustments are possible
Thus, in my clinical practice, given the uncertainty about B12 blood levels, if a patient has symptoms suggestive of B12 levels affecting cellular function, unless he/she wishes to undertake further testing with homocysteine and MMA, a trial of sublingual B12 in the active form at 1-2000 mcg daily (to avoid malabsorption issues) is a reasonable course of action
Learn more and book an appointment today
BPC-157 has demonstrated remarkably low toxicity with no established lethal dose, and its origin from human gastric juice suggests good biological compatibility
The goal is to relieve deficiency-related fatigue, not to provide a stimulant-like boost in people who are not deficient
The three components may degrade at slightly different rates